Novel motif:166: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif166_TAMAACTTTGS
|novel_motifs_human_sample_pval=11376-118A8_11051;0.325199,11327-117E4_11969;0.154545,11473-119C6_11054;0.0847174,11474-119C7_12067;...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:27, 9 September 2013
name: | motif166_TAMAACTTTGS |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050908 | detection of light stimulus involved in visual perception | 2.137858e-12 |
GO:0042325 | regulation of phosphorylation | 1.745712e-10 |
GO:0007417 | central nervous system development | 5.392206e-10 |
GO:0048513 | organ development | 5.796861e-10 |
GO:0006586 | indolalkylamine metabolic process | 9.031385e-10 |
GO:0019220 | regulation of phosphate metabolic process | 1.316276e-9 |
GO:0001932 | regulation of protein phosphorylation | 1.649415e-9 |
GO:0016056 | rhodopsin mediated signaling pathway | 1.985552e-9 |
GO:0030049 | muscle filament sliding | 3.609051e-9 |
GO:0048660 | regulation of smooth muscle cell proliferation | 3.884730e-9 |
GO:0003012 | muscle system process | 4.606824e-9 |
GO:0070252 | actin-mediated cell contraction | 1.159440e-8 |
GO:0006569 | tryptophan catabolic process | 1.434171e-8 |
GO:0006568 | tryptophan metabolic process | 1.868352e-8 |
GO:0032501 | multicellular organismal process | 3.035098e-8 |
GO:0006936 | muscle contraction | 3.992397e-8 |
GO:0051338 | regulation of transferase activity | 4.794731e-8 |
GO:0045859 | regulation of protein kinase activity | 5.266657e-8 |
GO:0048856 | anatomical structure development | 5.616257e-8 |
GO:0009584 | detection of visible light | 6.106102e-8 |
GO:0009888 | tissue development | 6.803197e-8 |
GO:0030301 | cholesterol transport | 6.892248e-8 |
GO:0019805 | quinolinate biosynthetic process | 7.764623e-8 |
GO:0042769 | DNA damage response, detection of DNA damage | 8.062539e-8 |
GO:0019441 | tryptophan catabolic process to kynurenine | 9.085353e-8 |
GO:0015918 | sterol transport | 9.291895e-8 |
GO:0048731 | system development | 9.442847e-8 |
GO:0031116 | positive regulation of microtubule polymerization | 1.064466e-7 |
GO:0006937 | regulation of muscle contraction | 1.309006e-7 |
GO:0030048 | actin filament-based movement | 1.332247e-7 |
GO:0044057 | regulation of system process | 1.461197e-7 |
GO:0043549 | regulation of kinase activity | 2.173713e-7 |
GO:0070189 | kynurenine metabolic process | 2.238790e-7 |
GO:0048729 | tissue morphogenesis | 2.811014e-7 |
GO:0031399 | regulation of protein modification process | 3.078936e-7 |
GO:0019363 | pyridine nucleotide biosynthetic process | 3.622568e-7 |
GO:0009583 | detection of light stimulus | 3.653085e-7 |
GO:0032502 | developmental process | 3.805653e-7 |
GO:0019362 | pyridine nucleotide metabolic process | 8.949050e-7 |
GO:0002088 | lens development in camera-type eye | 9.525954e-7 |
GO:0018874 | benzoate metabolic process | 9.678965e-7 |
GO:0007320 | insemination | 1.000100e-6 |
GO:0006928 | cellular component movement | 1.011527e-6 |
GO:0090257 | regulation of muscle system process | 1.383181e-6 |
GO:0007220 | Notch receptor processing | 1.508025e-6 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 2.030729e-6 |
GO:0046874 | quinolinate metabolic process | 2.039753e-6 |
GO:0018298 | protein-chromophore linkage | 2.093114e-6 |
GO:0052547 | regulation of peptidase activity | 2.131806e-6 |
GO:0019439 | aromatic compound catabolic process | 2.176137e-6 |
GO:0051346 | negative regulation of hydrolase activity | 2.236540e-6 |
GO:0014012 | peripheral nervous system axon regeneration | 2.258785e-6 |
GO:0009435 | NAD biosynthetic process | 2.377152e-6 |
GO:0007620 | copulation | 2.454483e-6 |
GO:0019674 | NAD metabolic process | 2.461073e-6 |
GO:0042946 | glucoside transport | 2.721445e-6 |
GO:0033344 | cholesterol efflux | 2.744522e-6 |
GO:0009586 | rhodopsin mediated phototransduction | 2.869154e-6 |
GO:0061097 | regulation of protein tyrosine kinase activity | 3.096201e-6 |
GO:0007026 | negative regulation of microtubule depolymerization | 3.343815e-6 |
GO:0042402 | cellular biogenic amine catabolic process | 3.384105e-6 |
GO:0034384 | high-density lipoprotein particle clearance | 3.447146e-6 |
GO:0047497 | mitochondrion transport along microtubule | 3.990130e-6 |
GO:0034516 | response to vitamin B6 | 4.038085e-6 |
GO:0043420 | anthranilate metabolic process | 4.038085e-6 |
GO:0034379 | very-low-density lipoprotein particle assembly | 4.666634e-6 |
GO:0010466 | negative regulation of peptidase activity | 5.751388e-6 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 6.069395e-6 |
GO:0043616 | keratinocyte proliferation | 6.544056e-6 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 6.971250e-6 |
GO:0031114 | regulation of microtubule depolymerization | 7.206262e-6 |
GO:0072321 | chaperone-mediated protein transport | 8.231867e-6 |
GO:0007618 | mating | 8.377552e-6 |
GO:0022414 | reproductive process | 8.515999e-6 |
GO:0000003 | reproduction | 8.941117e-6 |
GO:0014912 | negative regulation of smooth muscle cell migration | 9.241856e-6 |
GO:0042632 | cholesterol homeostasis | 9.416967e-6 |
GO:0035988 | chondrocyte proliferation | 9.430697e-6 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 9.501609e-6 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 9.710497e-6 |
GO:0007275 | multicellular organismal development | 9.946102e-6 |
GO:0046496 | nicotinamide nucleotide metabolic process | 1.081786e-5 |
GO:0031113 | regulation of microtubule polymerization | 1.089580e-5 |
GO:0002091 | negative regulation of receptor internalization | 1.092753e-5 |
GO:0031915 | positive regulation of synaptic plasticity | 1.160584e-5 |
GO:0009611 | response to wounding | 1.428990e-5 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 1.491707e-5 |
GO:0019371 | cyclooxygenase pathway | 1.766884e-5 |
GO:0051654 | establishment of mitochondrion localization | 1.960850e-5 |
GO:0003230 | cardiac atrium development | 2.375474e-5 |
GO:0035588 | G-protein coupled purinergic receptor signaling pathway | 2.489209e-5 |
GO:0010876 | lipid localization | 2.576211e-5 |
GO:0031102 | neuron projection regeneration | 2.583736e-5 |
GO:0016476 | regulation of embryonic cell shape | 2.614339e-5 |
GO:0003283 | atrial septum development | 2.655188e-5 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 2.828650e-5 |
GO:0043242 | negative regulation of protein complex disassembly | 2.882536e-5 |
GO:0007420 | brain development | 2.900913e-5 |
GO:0048631 | regulation of skeletal muscle tissue growth | 2.932249e-5 |
GO:0048632 | negative regulation of skeletal muscle tissue growth | 3.036665e-5 |
GO:0021782 | glial cell development | 3.123420e-5 |
GO:0007517 | muscle organ development | 3.225107e-5 |
GO:0048739 | cardiac muscle fiber development | 3.260512e-5 |
GO:0032268 | regulation of cellular protein metabolic process | 3.314351e-5 |
GO:0002548 | monocyte chemotaxis | 3.470231e-5 |
GO:0048676 | axon extension involved in development | 3.571934e-5 |
GO:0032147 | activation of protein kinase activity | 3.800794e-5 |
GO:0006600 | creatine metabolic process | 3.830871e-5 |
GO:0015910 | peroxisomal long-chain fatty acid import | 4.131548e-5 |
GO:0070375 | BMK cascade | 4.512676e-5 |
GO:0072358 | cardiovascular system development | 4.590212e-5 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 4.774770e-5 |
GO:0009074 | aromatic amino acid family catabolic process | 4.803671e-5 |
GO:0035435 | phosphate ion transmembrane transport | 4.992315e-5 |
GO:0043068 | positive regulation of programmed cell death | 5.094316e-5 |
GO:0003289 | atrial septum primum morphogenesis | 5.103619e-5 |
GO:0006941 | striated muscle contraction | 5.157525e-5 |
GO:0003357 | noradrenergic neuron differentiation | 5.202954e-5 |
GO:0042158 | lipoprotein biosynthetic process | 5.725215e-5 |
GO:0043010 | camera-type eye development | 6.075334e-5 |
GO:0052548 | regulation of endopeptidase activity | 6.121254e-5 |
GO:0006869 | lipid transport | 6.169098e-5 |
GO:0006916 | anti-apoptosis | 6.514013e-5 |
GO:0051494 | negative regulation of cytoskeleton organization | 6.597575e-5 |
GO:0042157 | lipoprotein metabolic process | 7.205969e-5 |
GO:0006959 | humoral immune response | 7.419168e-5 |
GO:0043065 | positive regulation of apoptosis | 7.680020e-5 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 7.911059e-5 |
GO:0001523 | retinoid metabolic process | 8.092709e-5 |
GO:0045073 | regulation of chemokine biosynthetic process | 8.301929e-5 |
GO:0043482 | cellular pigment accumulation | 8.465270e-5 |
GO:0043476 | pigment accumulation | 8.465270e-5 |
GO:0051348 | negative regulation of transferase activity | 8.495964e-5 |
GO:0071105 | response to interleukin-11 | 8.776609e-5 |
GO:0060429 | epithelium development | 8.863085e-5 |
GO:0043403 | skeletal muscle tissue regeneration | 9.191703e-5 |
GO:0051574 | positive regulation of histone H3-K9 methylation | 9.297636e-5 |
GO:0009072 | aromatic amino acid family metabolic process | 9.386310e-5 |
GO:0003209 | cardiac atrium morphogenesis | 9.556290e-5 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 9.900882e-5 |
GO:0001841 | neural tube formation | 9.941850e-5 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 1.026757e-4 |
GO:0045650 | negative regulation of macrophage differentiation | 1.026757e-4 |
GO:0045663 | positive regulation of myoblast differentiation | 1.064576e-4 |
GO:0008016 | regulation of heart contraction | 1.110406e-4 |
GO:0031960 | response to corticosteroid stimulus | 1.115478e-4 |
GO:0021915 | neural tube development | 1.139251e-4 |
GO:0046903 | secretion | 1.194826e-4 |
GO:0048854 | brain morphogenesis | 1.213992e-4 |
GO:0030505 | inorganic diphosphate transport | 1.228521e-4 |
GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 1.266315e-4 |
GO:0007399 | nervous system development | 1.283783e-4 |
GO:0016101 | diterpenoid metabolic process | 1.288031e-4 |
GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 1.291821e-4 |
GO:0051239 | regulation of multicellular organismal process | 1.308723e-4 |
GO:0006051 | N-acetylmannosamine metabolic process | 1.321531e-4 |
GO:0002384 | hepatic immune response | 1.330119e-4 |
GO:0009304 | tRNA transcription | 1.372286e-4 |
GO:0051901 | positive regulation of mitochondrial depolarization | 1.372286e-4 |
GO:0014706 | striated muscle tissue development | 1.385711e-4 |
GO:0042574 | retinal metabolic process | 1.424383e-4 |
GO:0043066 | negative regulation of apoptosis | 1.524929e-4 |
GO:0007340 | acrosome reaction | 1.540347e-4 |
GO:0060413 | atrial septum morphogenesis | 1.564082e-4 |
GO:0010942 | positive regulation of cell death | 1.566668e-4 |
GO:0060396 | growth hormone receptor signaling pathway | 1.612611e-4 |
GO:0009566 | fertilization | 1.615932e-4 |
GO:0014910 | regulation of smooth muscle cell migration | 1.626907e-4 |
GO:0002115 | store-operated calcium entry | 1.638214e-4 |
GO:0002009 | morphogenesis of an epithelium | 1.714062e-4 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.736310e-4 |
GO:0009581 | detection of external stimulus | 1.751225e-4 |
GO:0045937 | positive regulation of phosphate metabolic process | 1.804028e-4 |
GO:0070508 | cholesterol import | 1.825507e-4 |
GO:0006469 | negative regulation of protein kinase activity | 1.869667e-4 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 1.893909e-4 |
GO:0000022 | mitotic spindle elongation | 1.893909e-4 |
GO:0060056 | mammary gland involution | 1.925811e-4 |
GO:0002328 | pro-B cell differentiation | 1.954513e-4 |
GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 1.958918e-4 |
GO:0006721 | terpenoid metabolic process | 2.056911e-4 |
GO:0050713 | negative regulation of interleukin-1 beta secretion | 2.068337e-4 |
GO:0003065 | positive regulation of heart rate by epinephrine | 2.068337e-4 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 2.073901e-4 |
GO:0045638 | negative regulation of myeloid cell differentiation | 2.103355e-4 |
GO:0003281 | ventricular septum development | 2.110396e-4 |
GO:0032675 | regulation of interleukin-6 production | 2.117753e-4 |
GO:0030029 | actin filament-based process | 2.141908e-4 |
GO:0019953 | sexual reproduction | 2.177480e-4 |
GO:0031103 | axon regeneration | 2.202078e-4 |
GO:0046219 | indolalkylamine biosynthetic process | 2.245897e-4 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 2.263114e-4 |
GO:0010506 | regulation of autophagy | 2.276741e-4 |
GO:0046425 | regulation of JAK-STAT cascade | 2.346835e-4 |
GO:0031400 | negative regulation of protein modification process | 2.380787e-4 |
GO:0045936 | negative regulation of phosphate metabolic process | 2.461607e-4 |
GO:0015742 | alpha-ketoglutarate transport | 2.541783e-4 |
GO:0048469 | cell maturation | 2.547871e-4 |
GO:0090341 | negative regulation of secretion of lysosomal enzymes | 2.610308e-4 |
GO:0090188 | negative regulation of pancreatic juice secretion | 2.610308e-4 |
GO:0000296 | spermine transport | 2.653966e-4 |
GO:0070669 | response to interleukin-2 | 2.653966e-4 |
GO:0042981 | regulation of apoptosis | 2.657986e-4 |
GO:0051900 | regulation of mitochondrial depolarization | 2.709575e-4 |
GO:0007601 | visual perception | 2.723839e-4 |
GO:0001662 | behavioral fear response | 2.762089e-4 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 2.859010e-4 |
GO:0015810 | aspartate transport | 2.876830e-4 |
GO:0048853 | forebrain morphogenesis | 2.895256e-4 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 2.902873e-4 |
GO:0031296 | B cell costimulation | 2.997653e-4 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 3.012027e-4 |
GO:0032273 | positive regulation of protein polymerization | 3.057922e-4 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 3.096115e-4 |
GO:0042327 | positive regulation of phosphorylation | 3.110956e-4 |
GO:0055001 | muscle cell development | 3.152316e-4 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 3.290656e-4 |
GO:0071780 | mitotic cell cycle G2/M transition checkpoint | 3.305513e-4 |
GO:0042060 | wound healing | 3.309184e-4 |
GO:0050953 | sensory perception of light stimulus | 3.378647e-4 |
GO:0031018 | endocrine pancreas development | 3.406409e-4 |
GO:0045046 | protein import into peroxisome membrane | 3.415340e-4 |
GO:0043067 | regulation of programmed cell death | 3.434935e-4 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 3.542618e-4 |
GO:0035910 | ascending aorta morphogenesis | 3.542618e-4 |
GO:0033484 | nitric oxide homeostasis | 3.596358e-4 |
GO:0033673 | negative regulation of kinase activity | 3.615567e-4 |
GO:0040012 | regulation of locomotion | 3.619194e-4 |
GO:0046638 | positive regulation of alpha-beta T cell differentiation | 3.625835e-4 |
GO:0051606 | detection of stimulus | 3.644213e-4 |
GO:0042759 | long-chain fatty acid biosynthetic process | 3.663120e-4 |
GO:0009408 | response to heat | 3.729228e-4 |
GO:0034377 | plasma lipoprotein particle assembly | 3.767366e-4 |
GO:0060537 | muscle tissue development | 3.810768e-4 |
GO:0055088 | lipid homeostasis | 3.823761e-4 |
GO:0002209 | behavioral defense response | 3.852818e-4 |
GO:0046826 | negative regulation of protein export from nucleus | 3.876932e-4 |
GO:0048468 | cell development | 3.983630e-4 |
GO:0043069 | negative regulation of programmed cell death | 3.984809e-4 |
GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 4.213899e-4 |
GO:0048747 | muscle fiber development | 4.222489e-4 |
GO:0001779 | natural killer cell differentiation | 4.230890e-4 |
GO:0060840 | artery development | 4.317445e-4 |
GO:2000685 | positive regulation of cellular response to X-ray | 4.323879e-4 |
GO:2001038 | regulation of cellular response to drug | 4.323879e-4 |
GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining | 4.323879e-4 |
GO:0035978 | histone H2A-S139 phosphorylation | 4.323879e-4 |
GO:0031052 | chromosome breakage | 4.323879e-4 |
GO:0003131 | mesodermal-endodermal cell signaling | 4.323879e-4 |
GO:0032755 | positive regulation of interleukin-6 production | 4.327107e-4 |
GO:0007603 | phototransduction, visible light | 4.343530e-4 |
GO:0060271 | cilium morphogenesis | 4.374262e-4 |
GO:0006422 | aspartyl-tRNA aminoacylation | 4.399441e-4 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 4.453130e-4 |
GO:0009954 | proximal/distal pattern formation | 4.518352e-4 |
GO:0045578 | negative regulation of B cell differentiation | 4.523648e-4 |
GO:0006738 | nicotinamide riboside catabolic process | 4.537914e-4 |
GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway | 4.537914e-4 |
GO:0006148 | inosine catabolic process | 4.537914e-4 |
GO:0046825 | regulation of protein export from nucleus | 4.576609e-4 |
GO:0051146 | striated muscle cell differentiation | 4.602834e-4 |
GO:0048869 | cellular developmental process | 4.631122e-4 |
GO:0042755 | eating behavior | 4.679354e-4 |
GO:0048593 | camera-type eye morphogenesis | 4.684725e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 4.685503e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 4.685503e-4 |
GO:0048844 | artery morphogenesis | 4.707105e-4 |
GO:2000036 | regulation of stem cell maintenance | 4.827036e-4 |
GO:0034369 | plasma lipoprotein particle remodeling | 4.870299e-4 |
GO:0046637 | regulation of alpha-beta T cell differentiation | 4.992854e-4 |
GO:0051051 | negative regulation of transport | 5.127314e-4 |
GO:0048609 | multicellular organismal reproductive process | 5.286520e-4 |
GO:0042326 | negative regulation of phosphorylation | 5.341008e-4 |
GO:0060761 | negative regulation of response to cytokine stimulus | 5.346727e-4 |
GO:0006821 | chloride transport | 5.370306e-4 |
GO:0001654 | eye development | 5.457180e-4 |
GO:0032148 | activation of protein kinase B activity | 5.470644e-4 |
GO:0045738 | negative regulation of DNA repair | 5.522018e-4 |
GO:0046634 | regulation of alpha-beta T cell activation | 5.572718e-4 |
GO:0019369 | arachidonic acid metabolic process | 5.588578e-4 |
GO:0003181 | atrioventricular valve morphogenesis | 5.612911e-4 |
GO:0042572 | retinol metabolic process | 5.628385e-4 |
GO:0050711 | negative regulation of interleukin-1 secretion | 5.651851e-4 |
GO:0048170 | positive regulation of long-term neuronal synaptic plasticity | 5.684334e-4 |
GO:0048537 | mucosal-associated lymphoid tissue development | 5.698614e-4 |
GO:0030091 | protein repair | 5.923120e-4 |
GO:0016265 | death | 5.994302e-4 |
GO:0008219 | cell death | 6.056744e-4 |
GO:0048738 | cardiac muscle tissue development | 6.079750e-4 |
GO:0006776 | vitamin A metabolic process | 6.127277e-4 |
GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation | 6.160783e-4 |
GO:0048584 | positive regulation of response to stimulus | 6.186278e-4 |
GO:0031109 | microtubule polymerization or depolymerization | 6.308170e-4 |
GO:0003179 | heart valve morphogenesis | 6.368776e-4 |
GO:0014866 | skeletal myofibril assembly | 6.453159e-4 |
GO:0001934 | positive regulation of protein phosphorylation | 6.581305e-4 |
GO:0019087 | transformation of host cell by virus | 6.599858e-4 |
GO:0051384 | response to glucocorticoid stimulus | 6.654749e-4 |
GO:0006775 | fat-soluble vitamin metabolic process | 6.777880e-4 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 6.779201e-4 |
GO:0031032 | actomyosin structure organization | 6.779954e-4 |
GO:0060548 | negative regulation of cell death | 6.787618e-4 |
GO:0045540 | regulation of cholesterol biosynthetic process | 6.827866e-4 |
GO:0034754 | cellular hormone metabolic process | 6.850720e-4 |
GO:0071888 | macrophage apoptosis | 6.909441e-4 |
GO:0030334 | regulation of cell migration | 6.913340e-4 |
GO:0034605 | cellular response to heat | 6.966609e-4 |
GO:0072376 | protein activation cascade | 6.999946e-4 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 7.047442e-4 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 7.047442e-4 |
GO:0071726 | cellular response to diacyl bacterial lipopeptide | 7.066231e-4 |
GO:0042496 | detection of diacyl bacterial lipopeptide | 7.066231e-4 |
GO:2000145 | regulation of cell motility | 7.106703e-4 |
GO:0006895 | Golgi to endosome transport | 7.111043e-4 |
GO:0030595 | leukocyte chemotaxis | 7.134158e-4 |
GO:0006915 | apoptosis | 7.138416e-4 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 7.269091e-4 |
GO:0045649 | regulation of macrophage differentiation | 7.308042e-4 |
GO:0048514 | blood vessel morphogenesis | 7.440949e-4 |
GO:0032387 | negative regulation of intracellular transport | 7.471359e-4 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 7.513857e-4 |
GO:0055002 | striated muscle cell development | 7.550576e-4 |
GO:0002089 | lens morphogenesis in camera-type eye | 7.551207e-4 |
GO:0006953 | acute-phase response | 7.737713e-4 |
GO:0002253 | activation of immune response | 7.841544e-4 |
GO:0007602 | phototransduction | 7.843884e-4 |
GO:0012501 | programmed cell death | 7.888381e-4 |
GO:0032269 | negative regulation of cellular protein metabolic process | 8.032040e-4 |
GO:0031330 | negative regulation of cellular catabolic process | 8.141952e-4 |
GO:0043086 | negative regulation of catalytic activity | 8.156167e-4 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 8.185447e-4 |
GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway | 8.215287e-4 |
GO:0044092 | negative regulation of molecular function | 8.287395e-4 |
GO:2000366 | positive regulation of STAT protein import into nucleus | 8.346996e-4 |
GO:0070091 | glucagon secretion | 8.346996e-4 |
GO:0045214 | sarcomere organization | 8.516485e-4 |
GO:0072227 | metanephric macula densa development | 8.564674e-4 |
GO:0072240 | metanephric DCT cell differentiation | 8.564674e-4 |
GO:0030261 | chromosome condensation | 8.572279e-4 |
GO:0009653 | anatomical structure morphogenesis | 8.705148e-4 |
GO:0001838 | embryonic epithelial tube formation | 8.742542e-4 |
GO:0030239 | myofibril assembly | 8.755043e-4 |
GO:0070970 | interleukin-2 secretion | 8.833232e-4 |
GO:0050793 | regulation of developmental process | 8.957048e-4 |
GO:0007229 | integrin-mediated signaling pathway | 9.016594e-4 |
GO:0032490 | detection of molecule of bacterial origin | 9.043093e-4 |
GO:0008045 | motor axon guidance | 9.159302e-4 |
GO:0040007 | growth | 9.313101e-4 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 9.376171e-4 |
GO:0046635 | positive regulation of alpha-beta T cell activation | 9.497856e-4 |
GO:0035404 | histone-serine phosphorylation | 9.514086e-4 |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 9.682028e-4 |
GO:0034346 | positive regulation of type III interferon production | 9.772664e-4 |
GO:0007219 | Notch signaling pathway | 1.014203e-3 |
GO:0014009 | glial cell proliferation | 1.017055e-3 |
GO:0071104 | response to interleukin-9 | 1.055734e-3 |
GO:0051068 | dihydrolipoamide metabolic process | 1.055734e-3 |
GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 1.056480e-3 |
GO:0019915 | lipid storage | 1.056570e-3 |
GO:0030259 | lipid glycosylation | 1.062445e-3 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 1.063731e-3 |
GO:0021700 | developmental maturation | 1.107673e-3 |
GO:0033152 | immunoglobulin V(D)J recombination | 1.145606e-3 |
GO:0051570 | regulation of histone H3-K9 methylation | 1.149969e-3 |
GO:0006032 | chitin catabolic process | 1.160662e-3 |
GO:0001781 | neutrophil apoptosis | 1.163219e-3 |
GO:0072384 | organelle transport along microtubule | 1.165959e-3 |
GO:0003170 | heart valve development | 1.177609e-3 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.178810e-3 |
GO:0071477 | cellular hypotonic salinity response | 1.179723e-3 |
GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.179723e-3 |
GO:0048160 | primary follicle stage | 1.179723e-3 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.190551e-3 |
GO:0061061 | muscle structure development | 1.194590e-3 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 1.205945e-3 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 1.213292e-3 |
GO:0034375 | high-density lipoprotein particle remodeling | 1.215788e-3 |
GO:2000648 | positive regulation of stem cell proliferation | 1.228372e-3 |
GO:0071354 | cellular response to interleukin-6 | 1.235565e-3 |
GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 1.247763e-3 |
GO:2000026 | regulation of multicellular organismal development | 1.261529e-3 |
GO:0010970 | microtubule-based transport | 1.273910e-3 |
GO:2000683 | regulation of cellular response to X-ray | 1.306267e-3 |
GO:0072148 | epithelial cell fate commitment | 1.306267e-3 |
GO:0007507 | heart development | 1.311301e-3 |
GO:0070050 | neuron homeostasis | 1.316241e-3 |
GO:0007416 | synapse assembly | 1.326386e-3 |
GO:0030154 | cell differentiation | 1.339473e-3 |
GO:0060563 | neuroepithelial cell differentiation | 1.350006e-3 |
GO:0003161 | cardiac conduction system development | 1.377798e-3 |
GO:0019233 | sensory perception of pain | 1.385789e-3 |
GO:0055094 | response to lipoprotein stimulus | 1.401849e-3 |
GO:0034694 | response to prostaglandin stimulus | 1.410860e-3 |
GO:0031099 | regeneration | 1.428841e-3 |
GO:0035090 | maintenance of apical/basal cell polarity | 1.429248e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.429248e-3 |
GO:0009582 | detection of abiotic stimulus | 1.435079e-3 |
GO:0048863 | stem cell differentiation | 1.435613e-3 |
GO:0014048 | regulation of glutamate secretion | 1.439277e-3 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 1.440409e-3 |
GO:0016485 | protein processing | 1.443868e-3 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 1.499171e-3 |
GO:0010941 | regulation of cell death | 1.504239e-3 |
GO:0032989 | cellular component morphogenesis | 1.506023e-3 |
GO:0043691 | reverse cholesterol transport | 1.525645e-3 |
GO:0006323 | DNA packaging | 1.541305e-3 |
GO:0006692 | prostanoid metabolic process | 1.548074e-3 |
GO:0007197 | inhibition of adenylate cyclase activity by muscarinic acetylcholine receptor signaling pathway | 1.550231e-3 |
GO:0070779 | D-aspartate import | 1.562221e-3 |
GO:0035051 | cardiac cell differentiation | 1.577051e-3 |
GO:0006713 | glucocorticoid catabolic process | 1.584102e-3 |
GO:0050778 | positive regulation of immune response | 1.610618e-3 |
GO:0042427 | serotonin biosynthetic process | 1.615674e-3 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.626337e-3 |
GO:0003231 | cardiac ventricle development | 1.628895e-3 |
GO:0050900 | leukocyte migration | 1.644248e-3 |
GO:0072175 | epithelial tube formation | 1.657330e-3 |
GO:0008544 | epidermis development | 1.668529e-3 |
GO:0071827 | plasma lipoprotein particle organization | 1.671748e-3 |
GO:0034622 | cellular macromolecular complex assembly | 1.720025e-3 |
GO:0043244 | regulation of protein complex disassembly | 1.751722e-3 |
GO:0007506 | gonadal mesoderm development | 1.759457e-3 |
GO:0045666 | positive regulation of neuron differentiation | 1.769773e-3 |
GO:0061162 | establishment of monopolar cell polarity | 1.806397e-3 |
GO:0048545 | response to steroid hormone stimulus | 1.811782e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.813251e-3 |
GO:0070633 | transepithelial transport | 1.813827e-3 |
GO:0016331 | morphogenesis of embryonic epithelium | 1.852877e-3 |
GO:0050706 | regulation of interleukin-1 beta secretion | 1.865548e-3 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.885136e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 1.892016e-3 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.892035e-3 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.919554e-3 |
GO:0032757 | positive regulation of interleukin-8 production | 1.924631e-3 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.940090e-3 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 1.940198e-3 |
GO:0042976 | activation of Janus kinase activity | 1.940198e-3 |
GO:0032728 | positive regulation of interferon-beta production | 1.947493e-3 |
GO:0006952 | defense response | 1.951983e-3 |
GO:0071345 | cellular response to cytokine stimulus | 1.989289e-3 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.023286e-3 |
GO:0016572 | histone phosphorylation | 2.023822e-3 |
GO:0008054 | cyclin catabolic process | 2.025190e-3 |
GO:0003007 | heart morphogenesis | 2.033722e-3 |
GO:0043603 | cellular amide metabolic process | 2.045700e-3 |
GO:0045089 | positive regulation of innate immune response | 2.062180e-3 |
GO:0007156 | homophilic cell adhesion | 2.063086e-3 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 2.083895e-3 |
GO:0014003 | oligodendrocyte development | 2.099443e-3 |
GO:0048634 | regulation of muscle organ development | 2.132268e-3 |
GO:0048675 | axon extension | 2.153359e-3 |
GO:0043589 | skin morphogenesis | 2.156811e-3 |
GO:0071702 | organic substance transport | 2.166341e-3 |
GO:0048769 | sarcomerogenesis | 2.169947e-3 |
GO:0007010 | cytoskeleton organization | 2.176994e-3 |
GO:0065009 | regulation of molecular function | 2.194190e-3 |
GO:0001843 | neural tube closure | 2.204898e-3 |
GO:0032940 | secretion by cell | 2.204980e-3 |
GO:0050790 | regulation of catalytic activity | 2.211024e-3 |
GO:0035587 | purinergic receptor signaling pathway | 2.213038e-3 |
GO:0071103 | DNA conformation change | 2.216989e-3 |
GO:0002090 | regulation of receptor internalization | 2.224790e-3 |
GO:0009266 | response to temperature stimulus | 2.229988e-3 |
GO:0071167 | ribonucleoprotein complex import into nucleus | 2.243749e-3 |
GO:0018924 | mandelate metabolic process | 2.243749e-3 |
GO:0035279 | mRNA cleavage involved in gene silencing by miRNA | 2.260127e-3 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 2.271890e-3 |
GO:0070340 | detection of bacterial lipopeptide | 2.277540e-3 |
GO:0060118 | vestibular receptor cell development | 2.284902e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 2.299701e-3 |
GO:0001933 | negative regulation of protein phosphorylation | 2.319882e-3 |
GO:0035909 | aorta morphogenesis | 2.347562e-3 |
GO:0034121 | regulation of toll-like receptor signaling pathway | 2.356581e-3 |
GO:0016601 | Rac protein signal transduction | 2.376537e-3 |
GO:0031647 | regulation of protein stability | 2.385897e-3 |
GO:0007442 | hindgut morphogenesis | 2.416287e-3 |
GO:0051885 | positive regulation of anagen | 2.424445e-3 |
GO:0014835 | myoblast cell differentiation involved in skeletal muscle regeneration | 2.424445e-3 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.450946e-3 |
GO:0002224 | toll-like receptor signaling pathway | 2.487877e-3 |
GO:0042596 | fear response | 2.493708e-3 |
GO:0048541 | Peyer's patch development | 2.636429e-3 |
GO:0042063 | gliogenesis | 2.636703e-3 |
GO:0021509 | roof plate formation | 2.652448e-3 |
GO:0003008 | system process | 2.660492e-3 |
GO:0042692 | muscle cell differentiation | 2.746841e-3 |
GO:0050881 | musculoskeletal movement | 2.747592e-3 |
GO:0050776 | regulation of immune response | 2.757927e-3 |
GO:0030900 | forebrain development | 2.761303e-3 |
GO:0035458 | cellular response to interferon-beta | 2.767874e-3 |
GO:0051347 | positive regulation of transferase activity | 2.772178e-3 |
GO:0045860 | positive regulation of protein kinase activity | 2.774587e-3 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.792776e-3 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.792776e-3 |
GO:0072202 | cell differentiation involved in metanephros development | 2.815447e-3 |
GO:0001973 | adenosine receptor signaling pathway | 2.821722e-3 |
GO:0014061 | regulation of norepinephrine secretion | 2.836714e-3 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 2.837968e-3 |
GO:0002757 | immune response-activating signal transduction | 2.847238e-3 |
GO:0051129 | negative regulation of cellular component organization | 2.878999e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0014826 | vein smooth muscle contraction | 2.894301e-9 |
GO:0002087 | regulation of respiratory gaseous exchange by neurological system process | 5.261799e-9 |
GO:0001755 | neural crest cell migration | 1.251563e-8 |
GO:0070189 | kynurenine metabolic process | 4.210996e-8 |
GO:0035645 | enteric smooth muscle cell differentiation | 5.050280e-8 |
GO:0007497 | posterior midgut development | 5.050280e-8 |
GO:2000507 | positive regulation of energy homeostasis | 7.773370e-8 |
GO:2000253 | positive regulation of feeding behavior | 7.773370e-8 |
GO:0044065 | regulation of respiratory system process | 8.188364e-8 |
GO:0009992 | cellular water homeostasis | 8.304361e-8 |
GO:0070255 | regulation of mucus secretion | 1.605145e-7 |
GO:0014003 | oligodendrocyte development | 2.635163e-7 |
GO:0009072 | aromatic amino acid family metabolic process | 2.978584e-7 |
GO:0006568 | tryptophan metabolic process | 6.378878e-7 |
GO:0007512 | adult heart development | 7.077132e-7 |
GO:2000505 | regulation of energy homeostasis | 8.001147e-7 |
GO:0003219 | cardiac right ventricle formation | 1.025285e-6 |
GO:0043576 | regulation of respiratory gaseous exchange | 1.119100e-6 |
GO:0019432 | triglyceride biosynthetic process | 1.260702e-6 |
GO:0007018 | microtubule-based movement | 1.509654e-6 |
GO:0035411 | catenin import into nucleus | 1.616263e-6 |
GO:0042402 | cellular biogenic amine catabolic process | 2.293854e-6 |
GO:0070233 | negative regulation of T cell apoptosis | 2.445196e-6 |
GO:0002674 | negative regulation of acute inflammatory response | 2.549427e-6 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 2.607505e-6 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 2.651109e-6 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 2.834191e-6 |
GO:0051648 | vesicle localization | 2.919055e-6 |
GO:0019441 | tryptophan catabolic process to kynurenine | 3.092649e-6 |
GO:0042310 | vasoconstriction | 3.136785e-6 |
GO:0014043 | negative regulation of neuron maturation | 4.058512e-6 |
GO:0032463 | negative regulation of protein homooligomerization | 4.812177e-6 |
GO:0071985 | multivesicular body sorting pathway | 5.092090e-6 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 5.092090e-6 |
GO:0070256 | negative regulation of mucus secretion | 5.092090e-6 |
GO:0031100 | organ regeneration | 5.207402e-6 |
GO:0022010 | central nervous system myelination | 6.310562e-6 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.484025e-6 |
GO:0007416 | synapse assembly | 6.543346e-6 |
GO:0016080 | synaptic vesicle targeting | 6.765801e-6 |
GO:0006903 | vesicle targeting | 7.596720e-6 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 8.277158e-6 |
GO:0090066 | regulation of anatomical structure size | 8.319227e-6 |
GO:0030900 | forebrain development | 8.778703e-6 |
GO:0097113 | alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering | 9.653754e-6 |
GO:0048384 | retinoic acid receptor signaling pathway | 9.899941e-6 |
GO:0048625 | myoblast cell fate commitment | 1.087090e-5 |
GO:0050808 | synapse organization | 1.117120e-5 |
GO:0008217 | regulation of blood pressure | 1.244856e-5 |
GO:0002021 | response to dietary excess | 1.251105e-5 |
GO:0097115 | neurexin clustering | 1.282703e-5 |
GO:0006928 | cellular component movement | 1.349338e-5 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.359749e-5 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 1.617277e-5 |
GO:0032252 | secretory granule localization | 1.666719e-5 |
GO:0050925 | negative regulation of negative chemotaxis | 1.759392e-5 |
GO:0051640 | organelle localization | 1.787372e-5 |
GO:0061032 | visceral serous pericardium development | 2.017453e-5 |
GO:0030326 | embryonic limb morphogenesis | 2.158910e-5 |
GO:0042733 | embryonic digit morphogenesis | 2.225333e-5 |
GO:0072177 | mesonephric duct development | 2.285218e-5 |
GO:0043486 | histone exchange | 2.350500e-5 |
GO:0051130 | positive regulation of cellular component organization | 2.485251e-5 |
GO:0045022 | early endosome to late endosome transport | 2.698373e-5 |
GO:0072171 | mesonephric tubule morphogenesis | 3.361527e-5 |
GO:0032273 | positive regulation of protein polymerization | 3.384149e-5 |
GO:0001986 | negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure | 3.391990e-5 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 3.490330e-5 |
GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway | 3.532892e-5 |
GO:0046621 | negative regulation of organ growth | 3.596906e-5 |
GO:0032900 | negative regulation of neurotrophin production | 3.657766e-5 |
GO:0032244 | positive regulation of nucleoside transport | 3.657766e-5 |
GO:0002639 | positive regulation of immunoglobulin production | 3.672887e-5 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 3.912381e-5 |
GO:0031099 | regeneration | 4.298736e-5 |
GO:0006072 | glycerol-3-phosphate metabolic process | 4.767926e-5 |
GO:0009074 | aromatic amino acid family catabolic process | 4.960152e-5 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 5.124539e-5 |
GO:0002115 | store-operated calcium entry | 5.124539e-5 |
GO:0034509 | centromeric core chromatin assembly | 5.264461e-5 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 5.264461e-5 |
GO:0007158 | neuron cell-cell adhesion | 5.961042e-5 |
GO:0043254 | regulation of protein complex assembly | 6.266749e-5 |
GO:0051656 | establishment of organelle localization | 6.476999e-5 |
GO:0014829 | vascular smooth muscle contraction | 6.608076e-5 |
GO:0048709 | oligodendrocyte differentiation | 7.242472e-5 |
GO:0060065 | uterus development | 7.343632e-5 |
GO:0007157 | heterophilic cell-cell adhesion | 7.694011e-5 |
GO:0072208 | metanephric smooth muscle tissue development | 8.437921e-5 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 8.437921e-5 |
GO:0072259 | metanephric interstitial cell development | 8.437921e-5 |
GO:0072184 | renal vesicle progenitor cell differentiation | 8.437921e-5 |
GO:0072169 | specification of posterior mesonephric tubule identity | 8.437921e-5 |
GO:0072168 | specification of anterior mesonephric tubule identity | 8.437921e-5 |
GO:0001941 | postsynaptic membrane organization | 8.593048e-5 |
GO:0045329 | carnitine biosynthetic process | 8.646134e-5 |
GO:0060560 | developmental growth involved in morphogenesis | 8.704308e-5 |
GO:0019852 | L-ascorbic acid metabolic process | 8.864019e-5 |
GO:0051963 | regulation of synapse assembly | 9.094498e-5 |
GO:0048246 | macrophage chemotaxis | 9.710661e-5 |
GO:0051495 | positive regulation of cytoskeleton organization | 9.961275e-5 |
GO:0046590 | embryonic leg morphogenesis | 1.008810e-4 |
GO:0030049 | muscle filament sliding | 1.020779e-4 |
GO:0010463 | mesenchymal cell proliferation | 1.078199e-4 |
GO:0030322 | stabilization of membrane potential | 1.098828e-4 |
GO:0007522 | visceral muscle development | 1.149158e-4 |
GO:0021987 | cerebral cortex development | 1.196982e-4 |
GO:0006586 | indolalkylamine metabolic process | 1.225638e-4 |
GO:0042401 | cellular biogenic amine biosynthetic process | 1.244850e-4 |
GO:0072162 | metanephric mesenchymal cell differentiation | 1.249191e-4 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 1.306249e-4 |
GO:0014032 | neural crest cell development | 1.353030e-4 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.374542e-4 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 1.396744e-4 |
GO:0048619 | embryonic hindgut morphogenesis | 1.400652e-4 |
GO:0097120 | receptor localization to synapse | 1.509677e-4 |
GO:0072578 | neurotransmitter-gated ion channel clustering | 1.509677e-4 |
GO:0060323 | head morphogenesis | 1.589540e-4 |
GO:0046463 | acylglycerol biosynthetic process | 1.672476e-4 |
GO:0045210 | FasL biosynthetic process | 1.676194e-4 |
GO:0002554 | serotonin secretion by platelet | 1.713186e-4 |
GO:0072172 | mesonephric tubule formation | 1.771632e-4 |
GO:0014041 | regulation of neuron maturation | 1.771632e-4 |
GO:0050727 | regulation of inflammatory response | 1.779623e-4 |
GO:0035110 | leg morphogenesis | 1.944553e-4 |
GO:0015833 | peptide transport | 1.951168e-4 |
GO:0045212 | neurotransmitter receptor biosynthetic process | 1.969450e-4 |
GO:0007417 | central nervous system development | 1.988330e-4 |
GO:0072143 | mesangial cell development | 1.994079e-4 |
GO:0060982 | coronary artery morphogenesis | 1.994079e-4 |
GO:0050807 | regulation of synapse organization | 2.018017e-4 |
GO:0045668 | negative regulation of osteoblast differentiation | 2.047945e-4 |
GO:0030538 | embryonic genitalia morphogenesis | 2.056383e-4 |
GO:0048468 | cell development | 2.199331e-4 |
GO:0006954 | inflammatory response | 2.236058e-4 |
GO:0051650 | establishment of vesicle localization | 2.350208e-4 |
GO:0032462 | regulation of protein homooligomerization | 2.512142e-4 |
GO:0002637 | regulation of immunoglobulin production | 2.570916e-4 |
GO:0006916 | anti-apoptosis | 2.609374e-4 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 2.709952e-4 |
GO:0006258 | UDP-glucose catabolic process | 2.709952e-4 |
GO:0019439 | aromatic compound catabolic process | 2.712446e-4 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 2.746346e-4 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 2.746346e-4 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 2.746346e-4 |
GO:0051099 | positive regulation of binding | 2.887109e-4 |
GO:0002040 | sprouting angiogenesis | 2.974843e-4 |
GO:0048713 | regulation of oligodendrocyte differentiation | 3.026675e-4 |
GO:0046504 | glycerol ether biosynthetic process | 3.064848e-4 |
GO:0060173 | limb development | 3.078905e-4 |
GO:0060763 | mammary duct terminal end bud growth | 3.092917e-4 |
GO:2000409 | positive regulation of T cell extravasation | 3.132012e-4 |
GO:0043310 | negative regulation of eosinophil degranulation | 3.132012e-4 |
GO:0035705 | T-helper 17 cell chemotaxis | 3.132012e-4 |
GO:0018872 | arsonoacetate metabolic process | 3.132012e-4 |
GO:0035696 | monocyte extravasation | 3.132012e-4 |
GO:0034766 | negative regulation of ion transmembrane transport | 3.135998e-4 |
GO:0035659 | Wnt receptor signaling pathway involved in wound healing, spreading of epidermal cells | 3.135998e-4 |
GO:0014719 | satellite cell activation | 3.135998e-4 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 3.135998e-4 |
GO:0021543 | pallium development | 3.176820e-4 |
GO:0072180 | mesonephric duct morphogenesis | 3.183688e-4 |
GO:0061325 | cell proliferation involved in outflow tract morphogenesis | 3.183688e-4 |
GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis | 3.183688e-4 |
GO:0035385 | Roundabout signaling pathway | 3.222729e-4 |
GO:0021836 | chemorepulsion involved in postnatal olfactory bulb interneuron migration | 3.222729e-4 |
GO:0072178 | nephric duct morphogenesis | 3.553115e-4 |
GO:0016199 | axon midline choice point recognition | 3.787198e-4 |
GO:0001505 | regulation of neurotransmitter levels | 3.789083e-4 |
GO:0042759 | long-chain fatty acid biosynthetic process | 3.826082e-4 |
GO:0033189 | response to vitamin A | 3.861564e-4 |
GO:0032693 | negative regulation of interleukin-10 production | 4.011523e-4 |
GO:0060011 | Sertoli cell proliferation | 4.068115e-4 |
GO:0060325 | face morphogenesis | 4.090644e-4 |
GO:0050906 | detection of stimulus involved in sensory perception | 4.121161e-4 |
GO:0010912 | positive regulation of isomerase activity | 4.238951e-4 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 4.238951e-4 |
GO:0061360 | optic chiasma development | 4.303429e-4 |
GO:2000597 | positive regulation of optic nerve formation | 4.303429e-4 |
GO:0035799 | ureter maturation | 4.303429e-4 |
GO:0021633 | optic nerve structural organization | 4.303429e-4 |
GO:0002442 | serotonin secretion involved in inflammatory response | 4.303429e-4 |
GO:0021650 | vestibulocochlear nerve formation | 4.303429e-4 |
GO:0032459 | regulation of protein oligomerization | 4.327360e-4 |
GO:0040011 | locomotion | 4.470721e-4 |
GO:0007442 | hindgut morphogenesis | 4.524810e-4 |
GO:0060973 | cell migration involved in heart development | 4.544074e-4 |
GO:0014821 | phasic smooth muscle contraction | 4.556948e-4 |
GO:0051290 | protein heterotetramerization | 4.561580e-4 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 4.606217e-4 |
GO:0021795 | cerebral cortex cell migration | 4.780524e-4 |
GO:0001906 | cell killing | 4.814883e-4 |
GO:0000090 | mitotic anaphase | 5.132738e-4 |
GO:0042780 | tRNA 3'-end processing | 5.422221e-4 |
GO:0002576 | platelet degranulation | 5.422221e-4 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 5.640172e-4 |
GO:0034259 | negative regulation of Rho GTPase activity | 5.640172e-4 |
GO:0097105 | presynaptic membrane assembly | 5.817406e-4 |
GO:0030522 | intracellular receptor mediated signaling pathway | 5.867448e-4 |
GO:0044087 | regulation of cellular component biogenesis | 5.871953e-4 |
GO:0033273 | response to vitamin | 5.896411e-4 |
GO:0045213 | neurotransmitter receptor metabolic process | 5.924811e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 5.931172e-4 |
GO:0009956 | radial pattern formation | 5.949593e-4 |
GO:0032271 | regulation of protein polymerization | 6.010349e-4 |
GO:0048793 | pronephros development | 6.116885e-4 |
GO:0097091 | synaptic vesicle clustering | 6.158470e-4 |
GO:0043044 | ATP-dependent chromatin remodeling | 6.218204e-4 |
GO:2000353 | positive regulation of endothelial cell apoptosis | 6.326966e-4 |
GO:0010830 | regulation of myotube differentiation | 6.340884e-4 |
GO:0060167 | regulation of adenosine receptor signaling pathway | 6.406121e-4 |
GO:0003406 | retinal pigment epithelium development | 6.406121e-4 |
GO:0006952 | defense response | 6.489456e-4 |
GO:0002329 | pre-B cell differentiation | 6.602271e-4 |
GO:0007017 | microtubule-based process | 6.890785e-4 |
GO:0002707 | negative regulation of lymphocyte mediated immunity | 7.009476e-4 |
GO:0060324 | face development | 7.090030e-4 |
GO:0048484 | enteric nervous system development | 7.360305e-4 |
GO:0072017 | distal tubule development | 7.360305e-4 |
GO:0006071 | glycerol metabolic process | 7.386823e-4 |
GO:0045163 | clustering of voltage-gated potassium channels | 7.666217e-4 |
GO:0007172 | signal complex assembly | 7.666217e-4 |
GO:0032239 | regulation of nucleobase-containing compound transport | 7.666217e-4 |
GO:0050770 | regulation of axonogenesis | 7.675753e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 7.686547e-4 |
GO:0060070 | canonical Wnt receptor signaling pathway | 7.699534e-4 |
GO:0045017 | glycerolipid biosynthetic process | 7.728768e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 7.861658e-4 |
GO:0060998 | regulation of dendritic spine development | 8.147554e-4 |
GO:0010815 | bradykinin catabolic process | 8.166621e-4 |
GO:0090303 | positive regulation of wound healing | 8.184695e-4 |
GO:0008291 | acetylcholine metabolic process | 8.184695e-4 |
GO:0046110 | xanthine metabolic process | 8.184695e-4 |
GO:0046653 | tetrahydrofolate metabolic process | 8.256469e-4 |
GO:0051965 | positive regulation of synapse assembly | 8.274965e-4 |
GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback | 8.587677e-4 |
GO:0007409 | axonogenesis | 8.601702e-4 |
GO:0035726 | common myeloid progenitor cell proliferation | 8.716969e-4 |
GO:2000429 | negative regulation of neutrophil aggregation | 8.716969e-4 |
GO:2000469 | negative regulation of peroxidase activity | 8.716969e-4 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 8.716969e-4 |
GO:0002534 | cytokine production involved in inflammatory response | 8.716969e-4 |
GO:0032065 | cortical protein anchoring | 8.716969e-4 |
GO:0034276 | kynurenic acid biosynthetic process | 8.716969e-4 |
GO:2000243 | positive regulation of reproductive process | 8.853831e-4 |
GO:0030838 | positive regulation of actin filament polymerization | 9.021110e-4 |
GO:0045214 | sarcomere organization | 9.028211e-4 |
GO:0022029 | telencephalon cell migration | 9.209893e-4 |
GO:0001667 | ameboidal cell migration | 9.267265e-4 |
GO:0021827 | postnatal olfactory bulb interneuron migration | 9.361587e-4 |
GO:2000241 | regulation of reproductive process | 9.375607e-4 |
GO:0042981 | regulation of apoptosis | 9.661507e-4 |
GO:0048524 | positive regulation of viral reproduction | 9.811845e-4 |
GO:0042135 | neurotransmitter catabolic process | 9.935468e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 1.016638e-3 |
GO:0042492 | gamma-delta T cell differentiation | 1.043655e-3 |
GO:0043309 | regulation of eosinophil degranulation | 1.043655e-3 |
GO:0010832 | negative regulation of myotube differentiation | 1.051339e-3 |
GO:0044089 | positive regulation of cellular component biogenesis | 1.054410e-3 |
GO:0031344 | regulation of cell projection organization | 1.060372e-3 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.070989e-3 |
GO:0032846 | positive regulation of homeostatic process | 1.085826e-3 |
GO:0072203 | cell proliferation involved in metanephros development | 1.086384e-3 |
GO:0001909 | leukocyte mediated cytotoxicity | 1.089310e-3 |
GO:0045777 | positive regulation of blood pressure | 1.102452e-3 |
GO:0040023 | establishment of nucleus localization | 1.102519e-3 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 1.109506e-3 |
GO:0048293 | regulation of isotype switching to IgE isotypes | 1.119028e-3 |
GO:0043462 | regulation of ATPase activity | 1.121331e-3 |
GO:0019853 | L-ascorbic acid biosynthetic process | 1.137236e-3 |
GO:0097090 | presynaptic membrane organization | 1.153529e-3 |
GO:0050728 | negative regulation of inflammatory response | 1.168990e-3 |
GO:0032929 | negative regulation of superoxide anion generation | 1.198578e-3 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 1.198578e-3 |
GO:0006312 | mitotic recombination | 1.198578e-3 |
GO:0030719 | P granule organization | 1.198578e-3 |
GO:0021782 | glial cell development | 1.199787e-3 |
GO:0043067 | regulation of programmed cell death | 1.225003e-3 |
GO:0070257 | positive regulation of mucus secretion | 1.255326e-3 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.255326e-3 |
GO:0061205 | paramesonephric duct development | 1.255326e-3 |
GO:0019318 | hexose metabolic process | 1.265384e-3 |
GO:0010941 | regulation of cell death | 1.279958e-3 |
GO:0072176 | nephric duct development | 1.285211e-3 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 1.306617e-3 |
GO:0048668 | collateral sprouting | 1.312936e-3 |
GO:0007420 | brain development | 1.327390e-3 |
GO:0031348 | negative regulation of defense response | 1.334645e-3 |
GO:0048745 | smooth muscle tissue development | 1.342386e-3 |
GO:0009952 | anterior/posterior pattern specification | 1.343930e-3 |
GO:0046168 | glycerol-3-phosphate catabolic process | 1.344422e-3 |
GO:0042350 | GDP-L-fucose biosynthetic process | 1.344422e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 1.344671e-3 |
GO:0072678 | T cell migration | 1.348470e-3 |
GO:0090265 | positive regulation of immune complex clearance by monocytes and macrophages | 1.348470e-3 |
GO:0051466 | positive regulation of corticotropin-releasing hormone secretion | 1.348470e-3 |
GO:0006518 | peptide metabolic process | 1.372146e-3 |
GO:0001764 | neuron migration | 1.377048e-3 |
GO:0010975 | regulation of neuron projection development | 1.379626e-3 |
GO:0002076 | osteoblast development | 1.446871e-3 |
GO:0016198 | axon choice point recognition | 1.463139e-3 |
GO:0000723 | telomere maintenance | 1.478662e-3 |
GO:0048812 | neuron projection morphogenesis | 1.479656e-3 |
GO:0035116 | embryonic hindlimb morphogenesis | 1.491203e-3 |
GO:0006935 | chemotaxis | 1.495351e-3 |
GO:0050880 | regulation of blood vessel size | 1.512799e-3 |
GO:0021885 | forebrain cell migration | 1.517575e-3 |
GO:0032892 | positive regulation of organic acid transport | 1.521111e-3 |
GO:0009584 | detection of visible light | 1.521111e-3 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 1.537533e-3 |
GO:0002790 | peptide secretion | 1.564059e-3 |
GO:0002026 | regulation of the force of heart contraction | 1.566531e-3 |
GO:0035150 | regulation of tube size | 1.578637e-3 |
GO:0050434 | positive regulation of viral transcription | 1.588151e-3 |
GO:0060259 | regulation of feeding behavior | 1.607796e-3 |
GO:0031347 | regulation of defense response | 1.627441e-3 |
GO:0046459 | short-chain fatty acid metabolic process | 1.638573e-3 |
GO:0050803 | regulation of synapse structure and activity | 1.649262e-3 |
GO:0097070 | ductus arteriosus closure | 1.686404e-3 |
GO:0015871 | choline transport | 1.686404e-3 |
GO:0006749 | glutathione metabolic process | 1.692318e-3 |
GO:0060322 | head development | 1.712509e-3 |
GO:0042330 | taxis | 1.725177e-3 |
GO:0070933 | histone H4 deacetylation | 1.768796e-3 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 1.770602e-3 |
GO:0031334 | positive regulation of protein complex assembly | 1.772948e-3 |
GO:0031915 | positive regulation of synaptic plasticity | 1.776370e-3 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 1.781286e-3 |
GO:0008016 | regulation of heart contraction | 1.785544e-3 |
GO:0061162 | establishment of monopolar cell polarity | 1.789630e-3 |
GO:0035108 | limb morphogenesis | 1.820461e-3 |
GO:0009605 | response to external stimulus | 1.834442e-3 |
GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 1.859834e-3 |
GO:0071474 | cellular hyperosmotic response | 1.859834e-3 |
GO:0017121 | phospholipid scrambling | 1.859834e-3 |
GO:0014743 | regulation of muscle hypertrophy | 1.886778e-3 |
GO:0016445 | somatic diversification of immunoglobulins | 1.960656e-3 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 1.992771e-3 |
GO:0016202 | regulation of striated muscle tissue development | 1.998573e-3 |
GO:0014045 | establishment of endothelial blood-brain barrier | 2.002054e-3 |
GO:0031346 | positive regulation of cell projection organization | 2.002520e-3 |
GO:0032101 | regulation of response to external stimulus | 2.017766e-3 |
GO:0015909 | long-chain fatty acid transport | 2.018500e-3 |
GO:0006006 | glucose metabolic process | 2.079822e-3 |
GO:0070100 | negative regulation of chemokine-mediated signaling pathway | 2.083009e-3 |
GO:0050923 | regulation of negative chemotaxis | 2.083009e-3 |
GO:0006657 | CDP-choline pathway | 2.083009e-3 |
GO:0021562 | vestibulocochlear nerve development | 2.087720e-3 |
GO:0007156 | homophilic cell adhesion | 2.095411e-3 |
GO:0007599 | hemostasis | 2.100938e-3 |
GO:0002446 | neutrophil mediated immunity | 2.128152e-3 |
GO:0030168 | platelet activation | 2.162549e-3 |
GO:0021799 | cerebral cortex radially oriented cell migration | 2.180492e-3 |
GO:0050792 | regulation of viral reproduction | 2.183111e-3 |
GO:0070252 | actin-mediated cell contraction | 2.223066e-3 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 2.329918e-3 |
GO:0014823 | response to activity | 2.362904e-3 |
GO:0003215 | cardiac right ventricle morphogenesis | 2.379605e-3 |
GO:0042554 | superoxide anion generation | 2.435996e-3 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 2.477534e-3 |
GO:0048565 | digestive tract development | 2.480917e-3 |
GO:0050789 | regulation of biological process | 2.500877e-3 |
GO:0032211 | negative regulation of telomere maintenance via telomerase | 2.516019e-3 |
GO:0070869 | heterochromatin formation involved in chromatin silencing | 2.516019e-3 |
GO:0072075 | metanephric mesenchyme development | 2.518146e-3 |
GO:0034968 | histone lysine methylation | 2.520309e-3 |
GO:0008015 | blood circulation | 2.582010e-3 |
GO:0045926 | negative regulation of growth | 2.590851e-3 |
GO:0042364 | water-soluble vitamin biosynthetic process | 2.607360e-3 |
GO:0019400 | alditol metabolic process | 2.607433e-3 |
GO:0050777 | negative regulation of immune response | 2.620194e-3 |
GO:0032526 | response to retinoic acid | 2.695781e-3 |
GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 2.712455e-3 |
GO:0031333 | negative regulation of protein complex assembly | 2.753969e-3 |
GO:0040038 | polar body extrusion after meiotic divisions | 2.777781e-3 |
GO:0048634 | regulation of muscle organ development | 2.806328e-3 |
GO:0006408 | snRNA export from nucleus | 2.809416e-3 |
GO:0000722 | telomere maintenance via recombination | 2.809416e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 2.845005e-3 |
GO:0021526 | medial motor column neuron differentiation | 2.845005e-3 |
GO:0021891 | olfactory bulb interneuron development | 2.851926e-3 |
GO:0050772 | positive regulation of axonogenesis | 2.870834e-3 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 2.884164e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 2.938262e-3 |
GO:0032535 | regulation of cellular component size | 2.966025e-3 |
GO:0071375 | cellular response to peptide hormone stimulus | 2.969031e-3 |
GO:0045880 | positive regulation of smoothened signaling pathway | 3.088534e-3 |
GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 3.114182e-3 |
GO:0001937 | negative regulation of endothelial cell proliferation | 3.178591e-3 |
GO:0009309 | amine biosynthetic process | 3.183424e-3 |
GO:0051647 | nucleus localization | 3.209519e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 3.246364e-3 |
GO:2000193 | positive regulation of fatty acid transport | 3.319823e-3 |
GO:2000191 | regulation of fatty acid transport | 3.329955e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 3.336509e-3 |
GO:0007389 | pattern specification process | 3.347848e-3 |
GO:0032990 | cell part morphogenesis | 3.441162e-3 |
GO:0001676 | long-chain fatty acid metabolic process | 3.471454e-3 |
GO:0047497 | mitochondrion transport along microtubule | 3.494779e-3 |
GO:0033314 | mitotic cell cycle DNA replication checkpoint | 3.503903e-3 |
GO:0032789 | unsaturated monocarboxylic acid metabolic process | 3.503903e-3 |
GO:0015739 | sialic acid transport | 3.503903e-3 |
GO:0032788 | saturated monocarboxylic acid metabolic process | 3.503903e-3 |
GO:0009611 | response to wounding | 3.528905e-3 |
GO:0032200 | telomere organization | 3.536045e-3 |
GO:0030072 | peptide hormone secretion | 3.554576e-3 |
GO:0045685 | regulation of glial cell differentiation | 3.666424e-3 |
GO:0005996 | monosaccharide metabolic process | 3.685997e-3 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 3.699323e-3 |
GO:0031133 | regulation of axon diameter | 3.712849e-3 |
GO:0010763 | positive regulation of fibroblast migration | 3.712849e-3 |
GO:0003006 | developmental process involved in reproduction | 3.722281e-3 |
GO:0033275 | actin-myosin filament sliding | 3.767554e-3 |
GO:0002828 | regulation of type 2 immune response | 3.767910e-3 |
GO:0050908 | detection of light stimulus involved in visual perception | 3.831635e-3 |
GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | 3.831635e-3 |
GO:0007269 | neurotransmitter secretion | 3.905046e-3 |
GO:0021904 | dorsal/ventral neural tube patterning | 3.909633e-3 |
GO:0006278 | RNA-dependent DNA replication | 3.909633e-3 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 3.934715e-3 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 3.942919e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 3.942919e-3 |
GO:0003002 | regionalization | 4.006834e-3 |
GO:0009826 | unidimensional cell growth | 4.032385e-3 |
GO:0032210 | regulation of telomere maintenance via telomerase | 4.032385e-3 |
GO:0006837 | serotonin transport | 4.032602e-3 |
GO:0010611 | regulation of cardiac muscle hypertrophy | 4.155337e-3 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 4.212884e-3 |
GO:0061308 | cardiac neural crest cell development involved in heart development | 4.276941e-3 |
GO:0072166 | posterior mesonephric tubule development | 4.306448e-3 |
GO:0014807 | regulation of somitogenesis | 4.306448e-3 |
GO:0072194 | kidney smooth muscle tissue development | 4.306448e-3 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 4.306448e-3 |
GO:0006581 | acetylcholine catabolic process | 4.306448e-3 |
GO:0045918 | negative regulation of cytolysis | 4.345986e-3 |
GO:0006529 | asparagine biosynthetic process | 4.345986e-3 |
GO:0031641 | regulation of myelination | 4.355265e-3 |
GO:0032606 | type I interferon production | 4.416405e-3 |
GO:0051148 | negative regulation of muscle cell differentiation | 4.459610e-3 |
GO:0090193 | positive regulation of glomerulus development | 4.520628e-3 |
GO:0014050 | negative regulation of glutamate secretion | 4.520628e-3 |
GO:0032317 | regulation of Rap GTPase activity | 4.568435e-3 |
GO:0043627 | response to estrogen stimulus | 4.617427e-3 |
GO:0072044 | collecting duct development | 4.659873e-3 |
GO:0009583 | detection of light stimulus | 4.715899e-3 |
GO:0007614 | short-term memory | 4.808327e-3 |
GO:0048858 | cell projection morphogenesis | 4.813874e-3 |
GO:0021800 | cerebral cortex tangential migration | 4.839372e-3 |
GO:0045773 | positive regulation of axon extension | 4.915108e-3 |
GO:0014012 | peripheral nervous system axon regeneration | 4.977520e-3 |
GO:0072164 | mesonephric tubule development | 5.058828e-3 |
GO:0007548 | sex differentiation | 5.081940e-3 |
GO:0016180 | snRNA processing | 5.160677e-3 |
GO:0043388 | positive regulation of DNA binding | 5.171362e-3 |
GO:0033235 | positive regulation of protein sumoylation | 5.236645e-3 |
GO:0016337 | cell-cell adhesion | 5.244028e-3 |
GO:0007221 | positive regulation of transcription of Notch receptor target | 5.300040e-3 |
GO:0048676 | axon extension involved in development | 5.304060e-3 |
GO:0060040 | retinal bipolar neuron differentiation | 5.349867e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 5.349867e-3 |
GO:0016073 | snRNA metabolic process | 5.392248e-3 |
GO:0042270 | protection from natural killer cell mediated cytotoxicity | 5.392248e-3 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 5.497960e-3 |
GO:0071299 | cellular response to vitamin A | 5.549601e-3 |
GO:0001845 | phagolysosome assembly | 5.569979e-3 |
GO:0035418 | protein localization to synapse | 5.601603e-3 |
GO:0055123 | digestive system development | 5.776019e-3 |
GO:0032928 | regulation of superoxide anion generation | 5.800886e-3 |
GO:0014013 | regulation of gliogenesis | 5.824012e-3 |
GO:0006597 | spermine biosynthetic process | 5.855811e-3 |
GO:0002703 | regulation of leukocyte mediated immunity | 5.903515e-3 |
GO:0071205 | protein localization to juxtaparanode region of axon | 5.920677e-3 |
GO:0009755 | hormone-mediated signaling pathway | 5.948557e-3 |
GO:0031116 | positive regulation of microtubule polymerization | 5.967305e-3 |
GO:0050678 | regulation of epithelial cell proliferation | 5.989674e-3 |
GO:0006836 | neurotransmitter transport | 6.001478e-3 |
GO:0045346 | regulation of MHC class II biosynthetic process | 6.032382e-3 |
GO:0072221 | metanephric distal convoluted tubule development | 6.041828e-3 |
GO:0070327 | thyroid hormone transport | 6.041828e-3 |
GO:0051101 | regulation of DNA binding | 6.072767e-3 |
GO:0035455 | response to interferon-alpha | 6.166030e-3 |
GO:0032800 | receptor biosynthetic process | 6.169110e-3 |
GO:0051322 | anaphase | 6.181704e-3 |
GO:0065007 | biological regulation | 6.192323e-3 |
GO:0030833 | regulation of actin filament polymerization | 6.230345e-3 |
GO:0055091 | phospholipid homeostasis | 6.237045e-3 |
GO:0009214 | cyclic nucleotide catabolic process | 6.298441e-3 |
GO:0010970 | microtubule-based transport | 6.333494e-3 |
GO:0050794 | regulation of cellular process | 6.343384e-3 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 6.375931e-3 |
GO:0048870 | cell motility | 6.421234e-3 |
GO:0032620 | interleukin-17 production | 6.474651e-3 |
GO:0002365 | gamma-delta T cell lineage commitment | 6.474651e-3 |
GO:0017085 | response to insecticide | 6.511468e-3 |
GO:0051049 | regulation of transport | 6.538308e-3 |
GO:0048598 | embryonic morphogenesis | 6.542081e-3 |
GO:0048739 | cardiac muscle fiber development | 6.549893e-3 |
GO:0002697 | regulation of immune effector process | 6.601614e-3 |
GO:0045807 | positive regulation of endocytosis | 6.697157e-3 |
GO:0071300 | cellular response to retinoic acid | 6.749635e-3 |